Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

TCPA Earns Top Honors at Georgia Medical Directors Association Annual Conference

Leave a comment


TCPA Staff Recognized with Medical Director of the Year and Quality Champion Awards

ATLANTA, Sept. 15, 2023 /PRNewswire-PRWeb/ — Today, TCPA, one of the largest provider groups in Georgia that partners with skilled nursing facilities and senior-living communities to deliver in-home care for elderly patients, announced its staff had received the Medical Director of the Year and Quality Champion Awards by the Georgia Medical Directors Association – The Society for Post-Acute and Long-Term Care Medicine (GMDA).

GMDA accepts nominations and gives these awards annually. The Medical Director of the Year Award is given to the Certified Medical Director who demonstrates exceptional leadership in the nursing centers that he or she serves while the Quality Champion award is given to the individual who is most committed to promoting quality care for long-term care residents.

This year, Dr. Amar Mohan, Founder and CEO of TCPA, was recognized as the Medical Director of the Year while Dawn Coffee, NP, was recognized as the Quality Champion of the Year. It marks the first time in GMDA’s history that both awards were given to members from the same organization.

“Congratulations to TCPA on this accomplishment,” said Perry Kemp, Executive Director of TCPA. “They have established systems that highlight areas of concern and areas of accomplishment in nursing home care. They maintain a high expectation of improvement continually from his centers and teach them how to improve.”

“We are incredibly honored to receive both the Georgia Medical Director of the Year Award and the Quality Champion Award from the Georgia Medical Directors Association,” said Amar Mohan, MD, Founder and CEO of TCPA. “These awards are a testament to the hard work, dedication, and unwavering commitment of our entire team. We remain steadfast in our mission to provide the highest quality healthcare services to our community.”

The Georgia Medical Directors Association (GMDA) is dedicated to advancing the practice of post-acute and long-term care medicine in Georgia. Each year, the GMDA recognizes outstanding individuals and organizations that have demonstrated exceptional leadership, innovation, and dedication to quality healthcare.

About TCPA

TCPApartners with leading skilled nursing facilities and assisted living facilities to improve healthcare transitions and long-term care. TCPA’s unique, team-based care model complements primary care, maximizes care coordination, and enables early identification and response to healthcare risks. Our approach improves clinical outcomes, reduces healthcare costs, and enables our providers to develop meaningful personal relationships with their patients and focus on proactive, whole-person care. For more information, please visit http://www.tcpamd.com.

Media Contact

Brittny Catlett, TCPA, 1 (888) 772-0076, [email protected], https://www.tcpamd.com

SOURCE TCPA

Lifestyle: Self Help

Technological Advancements and Key Acquisitions Fuel the Aortic Aneurysm Market, Expected to Reach $4.84 Billion by 2027 with a CAGR of 9.21%

Leave a comment



DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Aortic Aneurysm Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global aortic aneurysm market is poised for robust growth, with projected revenues surging from $3.15 billion in 2022 to $3.41 billion in…

Health

UMDF, MitoAction Help Lift Up Patient Voices on FDA Listening Session for Pyruvate Dehydrogenase Complex Deficiency (PDCD)

Leave a comment


“The FDA heard courageous testimony about the toll this disease takes on patients, about the need for improved diagnostic and screening processes, and about the lengths caregivers are going to support the health of their loved ones. Above all, they heard about the urgent need for an approved treatment. Families are doing everything they can with the resources at their disposal, but this is a devastatingly progressive disease. As we work together to make an approved PDCD treatment a reality, it’s vital the process reflects that urgency,” said UMDF President and Chief Executive Officer Brian Harman.

“We thank the FDA for the opportunity to help their staff understand the PDCD community’s experiences and perspectives. It’s crucial that we continue to lift up the voices of expertise – patients, families, clinicians, and researchers – in forums like this,” he added.

Said MitoAction Chief Executive Officer Kira Mann: “As the patient-centered patient advocacy organization, we stand committed to fostering a space where the voices of those affected by mitochondrial diseases like PCDC can resonate. Just as we are dedicated to amplifying these voices, we also acknowledge the paramount significance of empowering patients and caregivers with knowledge about the FDA regulatory process. As advocates, we aim to empower individuals with the tools they need to actively engage in this critical process and ensure their voices are heard, because when patients are informed and engaged, they become a driving force for progress.”

UMDF and MitoAction thank the PDCD community members who bravely shared their stories and the many patient advocacy groups that helped make the listening session a success including Hope for PDCD and The Elizabeth Watt PDCD Research Fund.

Six caregivers to PDCD patients (one of whom is also an affected adult) participated in the FDA videoconference, along with clinician Rebecca Ganetzky, MD, of Children’s Hospital of Philadelphia.

Amongst the testimony heard was Emma, whose daughter Elizabeth is a 20-year-old patient with PDCD.

“As a family, we have lived in a crisis mode for the past 20 years. Constantly worried about death. We have already watched her regress medically and physically, and we fear that every illness will be the one that ends her life. Even minor illnesses can be catastrophic, so we live all day every day in fear. The sad fact is there is not a definitive treatment for PDCD,” she said. “Collectively, we come here today to ask for the hope that all people diagnosed with PDCD will be able to live a long and fulfilling life.”

This was the second FDA Listening Session UMDF and MitoAction have cohosted for a mitochondrial disease in the last 20 months. In January 2022, the FDA held a similar session for thymidine kinase 2 deficiency (TK2d), another rare mitochondrial disease.

ABOUT PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY

Pyruvate Dehydrogenase Complex Deficiency (PDCD) is a rare mitochondrial disorder that causes impaired carbohydrate metabolism, resulting in neurological problems and a buildup of a chemical called lactic acid in the blood. PDCD is caused by mutations in the genes that make up or affect the activity of the PDC, which is located in the mitochondria that make almost all the energy we need to survive. Nearly all individuals with PDCD experience developmental delay, poor muscle tone, and brain cell loss, which are often accompanied by a host of other issues. Like all mitochondrial diseases, there is currently no FDA-approved treatment or cure for PDCD.

ABOUT THE UNITED MITOCHONDRIAL DISEASE FOUNDATION

Founded in 1996, the United Mitochondrial Disease Foundation (UMDF) works to promote research and education for the diagnosis, treatment and cure of mitochondrial diseases and to provide support for affected individuals and families. Since its inception, the UMDF has funded more than $15 million in research, making it the leading non-governmental contributor of grants focused solely on mitochondrial disease. Every year, UMDF provides support and education to thousands of patients and medical professionals across the globe. Learn more at umdf.org.

ABOUT MITOACTION

Since 2005, MitoAction has transformed the lives of families affected by mitochondrial disease. Our mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives, and granting wishes for children affected by mitochondrial disease. Committed to making the largest impact possible, MitoAction serves individuals in the U.S. and worldwide through support, education, outreach, advocacy, and clinical research initiatives. The programs and services MitoAction provides continue to be a lifeline for families impacted by mitochondrial disease. Families know with MitoAction, they will never be alone on this difficult journey. Learn more at mitoaction.org.

Media Contact

Andy Dearth, United Mitochondrial Disease Foundation, 1 4129799833, [email protected], umdf.org

SOURCE United Mitochondrial Disease Foundation

Health

Mental Health Care Program for College Athletes Expands Reach to 25 Partnered Institutions

Leave a comment


From its inception, the organization has aimed to redefine mental health care standards by ensuring that every student-athlete receives the support they deserve. Taking a proactive approach, CBHA bridges the gap created by the stigma and hesitations often associated with seeking mental health assistance ensuring that every licensed professional has the necessary time to work with athletes that can lead to proper, long-term solutions.

This mission takes on added significance in light of recent statistics and stories on mental health issues. A recent study revealed an alarming record high of 49,500 suicides in the United States in 2022, emphasizing the urgent need for accessible mental health care.

Another article highlighted the current state of the therapy industry within the United States, with several being rushed out of appointments with ‘band-aid’ solutions such as ineffective medication.

Steve Wigginton, the Chief Executive Officer of CBHA, added to the company’s vision of being one of the top 5 mental health providers in the world by providing care to 100,000 to 200,000 patients per year. “We recognize the urgent need for change in the mental health care landscape,” Wigginton stated, “and we are dedicated to making that change happen. While our current priority is supporting athletes, our long-term vision includes expanding our services to reach the entire student body and all other entities in need of comprehensive mental health care within the United States. This is the transformation mental health care needs in this country.”

CBHA’s groundbreaking efforts are paving the way for a brighter future where mental health care is accessible, comprehensive, and compassionate, starting with college athletes.

Media Contact

Victor Torres, Collegiate Behavioral Health Associates, 1 8884891431 2009, [email protected], www.cbhamedical.com

Twitter, LinkedIn

SOURCE Collegiate Behavioral Health Associates



Health

NEDHSA announces Inaugural Recovery Celebration with September 15 event at Forsythe Park

Leave a comment


“People who experience mental illness and substance use disorders must receive the support they need when they need it,” Dr. Sizer said. “We know that behavioral health is essential to overall regional primary and population health outcomes. We also know that prevention works, treatment is effective, and people recover.”

“Our Recovery Day Celebration is specifically designed to encourage health-seeking behaviors and to build unity around what can unite us,” Dr. Sizer said. “This is why we continue to include our Arts as Medicine and related creative initiatives in the work we do. We must unify and thrive around the complex challenges we mutually face.”

The Recovery Day Celebration highlights and celebrates people in recovery from substance use and mental disorders, along with treatment providers promoting that recovery is possible in all forms. This day of celebration, within Recovery Month, is part of a national observance that promotes the societal benefits of prevention, treatment, and recovery. The event will feature speakers with lived experiences, NARCAN Training, health and wellness activities, interactive games and crafts, food, and music provided by SNAZZ Band.

NEDHSA’s Opioid Use Disorder Prevention Manager Kara J. Etienne, LMSW, said, “NEDHSA’s Recovery Day Celebration is not only for people in recovery but has been designed with the contributions of treatment and service providers in mind, and will also be a day for them to “celebrate” their contributions.”

“The day has been planned as a fun-filled, relaxing day that will bring together various agencies within NEDHSA’s catchment area and from other areas of the state to share resources and messages that will strengthen and renew hope, all while interacting through music, crafts, and games,” Etienne said.

The event is free and open to the public.

Media Contact

DeRon Talley, Northeast Delta HSA, 318-237-9973, [email protected], www.nedeltahsa.org

Twitter

SOURCE Northeast Delta HSA



health and fitness

Prevent Blindness Declares Third Annual Inflammatory Eye Disease Awareness Week as Sept. 18

Leave a comment


Prevent Blindness is also debuting a new episode in the online Focus on Eye Health Expert Series, “Uveitis and Inflammatory Eye Diseases.” Jeff Todd, president and CEO of Prevent Blindness, interviews Steven Yeh, MD, Professor and Stanley Truhlsen Jr. Chair of Ophthalmology, Truhlsen Eye Institute, University of Nebraska Medical Center. Dr. Yeh is also a volunteer on the Prevent Blindness Scientific Committee.

The uvea is a layer of the eye made up of three parts from the front to the back of the eye that helps provide nutrients to the eye. Uveitis is a term used to describe a group of inflammatory diseases or inflammation of the eye, which can be serious and lead to permanent vision loss. Uveitis causes about 30,000 new cases of blindness each year in the United States.

Signs and symptoms of uveitis include:

  • Eye redness
  • Eye pain
  • Light sensitivity
  • Blurred vision
  • Dark, floating spots in your field of vision (floaters)
  • Decreased vision

In addition to uveitis, there are many other types of IED. To help explain, Prevent Blindness offers the “Inflammatory Eye Disease” episode of the Focus on Eye Health Expert Series. This episode features Ann-Marie Lobo-Chan, MD, MS, of the Illinois Eye and Ear Infirmary, Associate Professor of Ophthalmology, Co-Director, Uveitis Service, University of Illinois College of Medicine, Department of Ophthalmology, and patient Addison Schwaller, Emergency Medicine Physician Assistant at Logansport Memorial Hospital in Logansport, Ind.

“Although ‘Inflammatory Eye Disease’ may not be a term that most people are familiar with, it is a condition that can have severe impact on vision if left untreated,” said Todd. “We encourage people to educate themselves on the various types of IEDs and whether they are at risk for, or have developed them already, to help prevent unnecessary vision loss.”

For more information on inflammatory eye disease, please visit https://preventblindness.org/inflammatory-eye-disease.
For a listing of vision care financial assistance programs in English or Spanish, visit https://preventblindness.org/vision-care-financial-assistance-information.

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn and YouTube.

Media Contact

Sarah Hecker, Prevent Blindness, 312.363.6035, [email protected], PreventBlindness.org

Twitter

SOURCE Prevent Blindness



Health: Psychology

Optimal Blue Acquired by Constellation Software’s Perseus Group

Leave a comment


“It’s an exciting day for the future of OB and the clients we serve,” said Kevin McMahon, CEO of Optimal Blue. “As a market leader in our space, we have a long history of delivering great solutions, and our clients have come to expect innovation that helps them drive loan profitability and process efficiency. Constellation’s ownership model positions us to further deliver on our commitment to rapid innovation for the benefit of our clients.”

“We have gotten to know the OB leadership team throughout our signing and due diligence process, and we are pleased to welcome the company to Perseus,” said Tom George, co-president of the Romulus portfolio of Perseus, who led the acquisition with Bonnie Wilhelm, COO of Perseus. “We look forward to working closely with them to support OB’s focus on serving clients and innovating as they continue to invest and keep their strong position as the leader in secondary marketing technology.”

About Optimal Blue
Optimal Blue is the market leader in mortgage secondary marketing technology. The company facilitates transactions among mortgage market participants through its Marketplace Platform, actionable data, and technology vendor connections. The platform supports a range of functions for originators and investors to automate and optimize core processes related to product, pricing, and eligibility, hedge analytics, MSR valuation, loan trading, social media compliance, and counterparty oversight. The company’s premier product, pricing and eligibility engine – the Optimal Blue PPE – is used by 64% of the top 500 mortgage lenders in the U.S. For more information on Optimal Blue’s end-to-end secondary marketing automation, visit https://www.OptimalBlue.com.

About Perseus and Constellation
As an operating group of Constellation Software Inc., Perseus acquires, manages and builds vertical market software businesses that provide mission-critical software solutions. As a long-term holder of companies, Constellation, through its operating groups including Perseus, has a proven track record of making investments in businesses with a clear focus on products, customers, and the teams that run the businesses. For more information about Perseus, visit the Perseus website at: https://www.csiperseus.com/. Further information about Constellation may be obtained from its website at: https://www.csisoftware.com/.

Media Contact

Alex Shreeve, Optimal Blue, 904.248.6826, [email protected]

SOURCE Optimal Blue

Health: Psychology

Global Cardiac Holter Monitor Market Research Report 2023: A $713.5 Million Market by 2030 – Wireless and AI-Integrated Holter Monitors Transforming Cardiovascular Health Monitoring

Leave a comment



DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Cardiac Holter Monitor Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. Global Cardiac Holter Monitor Market is…